Tag Archives: Patent and Trademark

Avatar Design & Construction Trademarks Brand, Unveils ‘Grand’ Multi-Family Developments

WATERTOWN, Mass. and MANCHESTER, N.H., Nov. 13, 2025 (SEND2PRESS NEWSWIRE) — Avatar Design & Construction, a leading commercial design-build firm, today announced the official trademarking of its company name (Avatar®) as a design-build brand and the launch of its new trademarked “Grand” line of multi-family apartment buildings. This strategic move solidifies the company’s identity and introduces a new standard of living to the New England market, beginning with three major projects in Manchester, New Hampshire.

Photo caption: GRAND Central Suites in Manchester NH – Bedroom Design.

The first development under the new brand, Grand Central Suites, is currently under construction at 21 Central Street in Manchester. The project is progressing steadily and is anticipated to welcome its first residents in early 2026. Following this flagship building, Avatar is set to break ground on two additional properties in Manchester: Grand Maison at 533 Elm Street and Grand Midtown at 102 Elm Street. These projects signal a significant expansion of the “Grand” brand and Avatar’s commitment to revitalizing urban communities throughout New England.

“Securing the trademarks for both Avatar and the ‘Grand’ brand is a pivotal milestone for our company,” said Nazar Vincent, President of Avatar Design & Construction. “It represents the culmination of our team’s dedication to creating exceptional spaces through our integrated design-build model. The ‘Grand’ properties are designed not just as buildings, but as vibrant communities, and we are thrilled to introduce this vision in Manchester and beyond.”

“We are excited to present Grand Central Suites to the community,” says the project’s developer, Nazar Vincent of Avatar Design & Construction. “This is the first of a series of projects that will not only provide top-notch living spaces but also contribute to the growth and development of Manchester’s downtown area. The wait is nearly over for those seeking a luxurious and modern living experience in the heart of downtown Manchester.”

INVESTMENT OPPORTUNITIES

Avatar Design & Construction invites interested investors to inquire about opportunities related to the “Grand” properties and other ongoing projects across the region. The firm continues to seek strategic partnerships to expand its portfolio of high-quality commercial and residential properties.

In partnership with Bridgewater Development of Watertown, MA, Avatar Design & Construction offers several attractive opportunities for qualified investors interested in high-yield commercial real estate investments. With a minimum investment of $50,000, individuals and groups can participate in the development of premier multi-family and mixed-use projects across the Northeast.

“Our purchasing experts leverage extensive research and global sourcing to secure exceptional products and building materials at significantly reduced costs,” says Nazar Vincent. “This purchasing advantage allows us to design projects with higher profit margins while upholding superior design standards and construction quality. As a result, we are proud to share these profits with a select group of investors who are instrumental in bringing our project portfolio to life.”

Investors have the flexibility to allocate funds to a single property or diversify across multiple developments. To learn more or apply, visit https://bridgewaterdevelopment.com/.

ABOUT AVATAR DESIGN & CONSTRUCTION

The Avatar® team has been building ideas into reality since 1999. Avatar Design & Construction is a full-service, design-build commercial construction company serving clients in Massachusetts and New Hampshire. With a history of completing projects on schedule and on budget, Avatar is a trusted partner for commercial, multi-family, and mixed-use developments. By integrating design, engineering, and construction management under one roof, the company streamlines the entire building process, delivering exceptional quality, cost-efficiency, and unparalleled client service from concept to completion.

We believe in a simple, yet extremely effective, approach to commercial construction – We call it Avatar Design + Build.

While many companies claim to offer design + build, few offer a solution that truly encompasses the entire project from start to finish and beyond. Over the years, we have developed and refined the Avatar Design/Build Process which has set us apart from others in the industry who cannot truly offer an A-Z design/build solution.

PROJECT CAPABILITIES

Avatar Construction, Inc. & Bridgewater Development are headquartered in Watertown Massachusetts and can be reached by calling (617) 714-5773 or through the corporate websites.

Learn more:

https://avatarconstructioninc.com/
https://bridgewaterdevelopment.com/
https://nazarvincent.com/
https://www.facebook.com/AvatarConstructionCorporation
https://www.instagram.com/avatarconstructioncorp/
https://www.linkedin.com/company/avatar-construction-boston

MEDIA CONTACT:
Nazar Vincent
+1 617-714-5773
nazar@avatarconstructioninc.com

MULTIMEDIA:
Photo link for media: https://www.Send2Press.com/300dpi/25-1113-s2p-grand-nh-300dpi.webp

Photo caption: GRAND Central Suites in Manchester NH – Bedroom Design.

NEWS SOURCE: Avatar Construction Inc.

This press release was issued on behalf of the news source (Avatar Construction Inc.), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/avatar-design-construction-trademarks-brand-unveils-grand-multi-family-developments/

DocMagic awarded dual patents for groundbreaking electronic loan document innovations

Patents advance fully digital mortgage closings

TORRANCE, Calif., Oct. 15, 2025 (SEND2PRESS NEWSWIRE) — DocMagic, Inc. announced today it has been granted two patents from the United States Patent and Trademark Office: Patent No. 12,175,785 for its system and method of “Determining Similar Loan Documents” and Patent No. 12,169,976 for its system and method of “Enabling Electronic Loan Documents.” Individually and collectively, the patents give DocMagic competitive exclusivity to technology that strengthens the company’s ability to automate document preparation and digital closing workflows.

Image caption: DocMagic awarded dual patents for groundbreaking electronic loan document innovations.

The issuance of these patents reflects the novelty of DocMagic’s inventions as determined by the U.S. Patent and Trademark Office. Both patented inventions are already integrated into DocMagic’s AutoPrep™ solution, which instantly converts third-party documents into e-ready files for eSignature, eNotarization and eClosing. This technology enables DocMagic to deliver more efficient, compliant and secure closing workflows.

“These patents represent a critical milestone toward universal adoption of digital closings,” said DocMagic co-founder and CEO Pat Theodora. “They reflect our decades-long commitment to innovation and our vision to continually push technological boundaries. This achievement honors the pioneering spirit that has defined DocMagic since its founding nearly 40 years ago.”

“Our focus has always been on removing friction from the mortgage process through technology,” said Michael Morford, DocMagic’s chief technology officer. “By combining AI, optical character recognition and patented technologies, DocMagic delivers an intuitive solution that instantly prepares documents for fully digital closings. These innovations transform how documents are prepared, executed and secured, creating a truly digital experience for lenders, borrowers and settlement agents.”

About DocMagic:

Founded in 1987 and headquartered in Torrance, California, DocMagic, Inc. is a leading provider of compliant document generation, automated compliance, eSignature and comprehensive eMortgage solutions for the mortgage industry. The company’s solutions facilitate precision-based digital lending transactions, connecting industry participants and ensuring data integrity. With in-house compliance experts and legal staff, DocMagic monitors legal and regulatory changes at both federal and state levels. For more information on DocMagic, visit https://www.docmagic.com/.

Tags: @DocMagicTech

NEWS SOURCE: DocMagic, Inc.

This press release was issued on behalf of the news source (DocMagic, Inc.), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/docmagic-awarded-dual-patents-for-groundbreaking-electronic-loan-document-innovations/

Zeteo Biomedical Secures Global Patents for Nasal and Ophthalmic Drug Delivery Device Innovations

CEDAR PARK, Texas, June 11, 2025 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical, a privately held biomedical device company, today announced the issuance of new patents in the United States and European Union for its advanced drug delivery technologies. The patents, titled “Cartridge Devices for Administration of a Medicament” (U.S. Patent No. 12329949) and “Hand-Operated Devices for Administration of a Medicament” (EU Patent No. 3946526), further strengthen Zeteo’s ZTech™ delivery platform portfolio for the administration of drugs and biologics via nasal, ophthalmic, and sublingual routes.

Image caption: Zeteo Biomedical.

These patented innovations advance Zeteo’s ZTech-L™ and ZTech-P™ delivery systems, which include both single-use disposable and multi-dose, cartridge-reloadable handheld devices. The platforms support the administration of therapeutics in both liquid and dry powder formulations, including vaccines, biologics, and specialty drugs. Nasal delivery, in particular, is emerging as a highly effective, non-invasive alternative for treating conditions such as pain, emesis, seizures, neurodegenerative and autoimmune disorders, infectious diseases, and bioterror threats.

“We are seeing increasing global demand for metered-dose nasal, ophthalmic, and sublingual delivery devices that are compact, intuitive, and suitable for self-administration,” said Timothy Sullivan, CEO of Zeteo Biomedical. “A unique feature that sets our device technology apart is its ability to function reliably in any physical orientation, making it ideal for medication delivery in both terrestrial and space-based microgravity environments. This capability opens exciting new frontiers for Zeteo including applications in space-based healthcare.”

Zeteo’s integrated delivery platforms and technical services streamline the development and commercial-scale production of patient-centric drug/device combination products for pharmaceutical and biotech partners. This focus on patient-friendly design improves treatment adherence and medical outcomes, while enhancing product differentiation and brand value for manufacturers.

Zeteo’s platform technologies are designed to meet the evolving demands of global and interstellar healthcare markets, delivering precision, performance, and portability for the next-generation of therapeutic drug/device combination products.

About Zeteo Biomedical LLC

Zeteo Biomedical is a Texas-based medical device company focused on the development and commercialization of advanced drug and biologic delivery systems. The company specializes in intranasal, ophthalmic, and sublingual delivery technologies designed to improve patient outcomes through precision dosing, portability, and ease of use. Zeteo’s proprietary platforms are supported by an extensive patent portfolio and a range of product development services tailored to accelerate time to market for pharmaceutical and biotech clients worldwide.

To learn more, visit https://zeteobiomed.com/.

MEDIA CONTACT:
Cathy Diehl
Zeteo Biomedical LLC
+(1) 512-614-0144
zeteo@zeteobiomed.com

*LOGO link for media: https://www.send2press.com/300dpi/20-1117s2p-zeteo-biomedical-300dpi.jpg

NEWS SOURCE: Zeteo Biomedical LLC

This press release was issued on behalf of the news source (Zeteo Biomedical LLC), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/zeteo-biomedical-secures-global-patents-for-nasal-and-ophthalmic-drug-delivery-device-innovations/

American West Water Advisors and Nash Announce Water Development Plan in NM

The Governor's Strategic Water Supply will revolutionize water markets in New Mexico

ALBUQUERQUE and SANTA FE, N.M., Dec. 4, 2024 (SEND2PRESS NEWSWIRE) — American West Water Advisors, LLC and process patent inventor, Marvin Nash announced that they have joined together to create “fit for purpose” to reuse brackish, by product, industrial and other waste waters for beneficial use that is both safe and affordable. John D’Antonio Jr., P .E., owner and principal of American West Water Advisors has a dedicated history in solving challenging water administration and infrastructure issues in the State of New Mexico and the western United States.

Photo caption: (L-R) John D’Antonio, Jr and NM Governor Michelle Lujan Grisham..

“New Mexico, as well as many other states, are searching for solutions to safely increase water supply through treatment and reuse,” Mr. D’Antonio said.

Marvin Nash is a veteran in both the oil field and the agricultural field. Like most inventions, his patent was brought about by need. The solution is the patent, “Method of Processing Industrial by Product Water for Optimal Beneficial Use.”

“Safety of the water is paramount and this patented process will work with any water treatment technology to give western states the water they need,” Mr. Nash added.

After a lengthy evaluation process, Mr. D’Antonio has joined Mr. Nash to help implement the “Conservation by Design Beneficial Use Method” (CBD) on projects in New Mexico. The CBD patent/prescriptive process will ensure safety of the public and environment as part of any treatment train process and application of treated water for beneficial use. Safety accountability at the back end of the process using the CBD patent will ensure regulatory compliance if pilot process advances to approved production later. CBD patent is compatible with any treatment technology used to clean the water and will confirm whether the end use of the treated water results in protecting human health and the environment.

“The Governor’s Strategic Water Supply will revolutionize water markets in New Mexico by increasing opportunities to augment fresh water supply by using treated brackish and produced water to support economic development and create opportunities for other uses-with safety verification using the CBD prescriptive process,” states Mr. D’Antonio.

For additional information on CBD or U.S. Patent #11844316, please contact: Marvin L. Nash at Marvin@MarvinNash.com or John D’Antonio Jr. at John@AmericanWestWater.com

MULTIMEDIA:

PHOTO link for media: https://www.send2press.com/300dpi/24-1204-s2p-DAntonioJr-and-Grisham-300dpi.jpg

Photo caption: (L-R) John D’Antonio, Jr and NM Governor Michelle Lujan Grisham.

MEDIA CONTACT:
Jeff Holder of
Jeff Holder Creative Agency
+1-818-470-0285
Jeff@JeffHolder.net

NEWS SOURCE: Marvin Nash

This press release was issued on behalf of the news source (Marvin Nash), who is solely responsible for its accuracy, by Send2Press Newswire. Image, if any, was provided by the news source and not this website or the wire service. Information is believed accurate, as provided by the news source, but is not guaranteed.

To view the original story, visit: https://www.send2press.com/wire/american-west-water-advisors-and-nash-announce-water-development-plan-in-nm/

Life Saving Device for Major Heart Surgery Procedure Now Available for Exclusive Manufacture

LOS ANGELES, Calif. /ScoopCloud/ -- ProNova Partners, a Los Angeles based, 25-year-old Mergers and Acquisitions (M&A) firm has announced their commission to facilitate the sale of a new, patented device to lower mortality and other risks in specific, major heart surgery procedures.

The device lowers mortality, stroke risk and other risk factors in Transcatheter Aortic Valve Implantation (TAVI) or transcatheter aortic valve replacement (TAVR) procedures.

"We are very pleased that our past work, both nationally and internationally, has enabled us now to assist in bringing a life-saving device to the market for manufacture," announced Rick Carlson CEO and founder of ProNova Partners.

ProNova Partners has facilitated the sale of over 400 various opportunities in divergent areas. "This broad range of experience and exposure in multiple areas of the marketplace has been very helpful to our consultation work in the medical and tech arenas," Carlson stated.

The patented device available for rights purchase can simply be added to existent equipment to immediately improve patient outcomes. It was developed by a renowned M.D. and professor, a prolific inventor who owns more than 20 issued U.S. and tens of International Patents and a similar number of pending patents.

According to the developer "The vision of our Project (was) to significantly improve the safety of TAVI/TAVR. Integrating or adding-on an active double-filtering, emboli capturing, collecting and removal component to the TAVI/TAVR procedure is a breakthrough. With our approach, we are bringing a better solution than the currently used deflective anti-embolic devices for preventing cerebral embolic complications."

"We are proud and pleased to be a part of offering the full rights and ownership into the marketplace for manufacture," concluded Carlson. "It will both save lives and improve quality of life immediately for hundreds of thousands of patients and once released those numbers will grow to millions."

For detailed information go to: https://pronovapartners.com/engagement/medical-device-company-for-major-heart-surgery-for-sale/

ProNova Partners, a Los Angeles based, 25-year-old Mergers and Acquisitions (M&A) firm has announced their commission to facilitate the sale of a new, patented device to lower mortality and other risks in specific, major heart surgery procedures.

Related link: https://www.pronovapartners.com/

Flyvito announces the registration of trademark for the name Flyvito just weeks after releasing the album ‘Collection’ to all streaming platforms

NEW ORLEANS, La. /ScoopCloud/ -- Flyvito® a well-established producer based in New Orleans, just announced the registering of his trademark Flyvito. This comes after years of working on major projects with artists worldwide. In an effort to verify the brand Flyvito, the producer has decided to register his trademark, and business Flyvito LLC in New Orleans. He hopes to generate additional leads through strategic monetization procedures, along with this verification of brand identity.

"At this point in my career, it's more about offering a seamless and credible product for individuals who wish to shop with me. I want every artist to know that if they work with Flyvito in any capacity, they are getting a genuine product from a credible business. Registering this trademark will provide the level of credibility necessary for these artists."

This information was announced just a few weeks after Flyvito released the album "Collection" through Sony on all streaming platforms. "Collection" is an album of collective instrumentals produced by Flyvito from the years 2010-2021.

More information: https://flyvito.com/

About Flyvito:

Based in New Orleans, Louisiana, Flyvito's unique sound and beat patterns derive from inspiration of Mannie Fresh, Just Blaze, Mouse on the Track and Zaytoven to name a few.

His presence on YouTube rose quickly to millions of views on videos from 2010-2015 and boasts several thousand subscribers.

Flyvito explains that his passion comes from hearing perfection in the beat patterns and melodies. "It's never been about the money for me. That's why for years I gave away music for free or for very low prices. I just love a great sound."

Enjoy Flyvito's catalog on https://flyvito.com/ and at http://teamflyness.com. He can be found on Instagram and Twitter @Fliiizle and YouTube @Flyvito respectively.

Flyvito® a well-established producer based in New Orleans, just announced the registering of his trademark Flyvito. This comes after years of working on major projects with artists worldwide. In an effort to verify the brand Flyvito, the producer has decided to register his trademark, and business Flyvito LLC in New Orleans.

Related link: https://flyvito.com/

By Light joins FSC Edge in 10-year contract supporting full lifecycle patent processing for the United States Patent and Trademark Office

MCLEAN, Va. /ScoopCloud/ -- By Light Professional IT Services LLC (By Light), as a primary subcontractor to Flatirons Solutions Corporation, a U.S. company, was awarded a contract by the United States Patent and Trademark Office (USPTO) for the Patent Data and Document Management (PDDM) program with a potential value of $1.4 billion.

The period of performance for the contract is ten (10) years if all options are exercised. Under this program, FSC Edge will support USPTO's management of the entire patent application life cycle from the initial filing of the application to the final disposition of the application.

By Light's contribution will focus on providing the US-based instance of the FSC Edge data capture and conversion solutions and migrating the solutions into a highly robust, economical, and secure cloud-based environment. Once in production, By Light will manage these environments and ensure ongoing superior performance and a continuously managed security posture.

"By Light's experience with complex software development utilizing Agile practices, DevSecOps, and a refined security assessment capability that leads to a granted Authority to Operate (ATO) capability aligns well with the objectives of the USPTO PDDM mission and blends well with the extremely talented FSC Edge team," says By Light CTO, Tom Ryan.

"FSC Edge is very pleased at being selected to serve the USPTO under the PDDM program with our partner By Light" noted FSC Edge CEO and President, David Goodman. "By Light is an essential element of FSC Edge's approach as they will establish our U.S.-based systems and the expansion of the data capture and conversion solution to handle the full requirements of the USPTO PDDM program."

About By Light

By Light Professional IT Services LLC, headquartered in McLean, Virginia, is an ISO 9001, 20000-1, and 27001 registered and CMMI Level 3 rated systems integrator that provides secure, turn-key systems by incorporating exceptional engineering, project management, telecommunications, and cyber capabilities to safeguard mission success. By Light successfully implements technical solutions that integrate commercial best practices to meet the needs of government. For more information, visit https://bylight.com/.

About FSC Edge

For over 20 years, the team at FSC Edge (http://www.fscedge.com) has been taking revolutionary steps to provide highly accurate and innovative services at a low cost. We strive to continue improving quality and lowering costs further to ensure our clients can receive the best services at the lowest cost to them. Our efficient data capture and conversion services handle high volumes of information for intellectual property offices at the international level.

By Light Professional IT Services LLC (By Light), as a primary subcontractor to Flatirons Solutions Corporation, a U.S. company, was awarded a contract by the United States Patent and Trademark Office (USPTO) for the Patent Data and Document Management (PDDM) program with a potential value of $1.4 billion.

Related link: https://www.bylight.com/

Bug-A-Salt Wins Settlement Over Dillard’s Dept. Store

SANTA MONICA, Calif. /ScoopCloud/ -- Bug-A-Salt (a subsidiary of Skell Inc.) this month prevailed in a patent and trademark infringement lawsuit against Dillard's Department Stores, according to the Bug-A-Salt, attorney, Liat Cohen, Esq.

Dillard's, in a settlement, paid an undisclosed sum of money for selling counterfeit Bug-A-Salt guns to kill flies, mosquitos, and other insects. The case number is 1:20-CV-O1567-UNA and was filed in United States District Court of Delaware.

Lorenzo Maggiore, CEO of Skell Inc., and inventor of the Bug-A-Salt, stated "We have a zero-tolerance policy against pirates and other knock-off artists who try to profit from our product and we will take action to protect our Intellectual Property rights from any of these counterfeiters."

The lawsuit was initiated by Skell's attorney, Liat Cohen, who zealously took steps to see the case moved through the legal system with maximum effect.

"Liat (Cohen) has assisted us on many issues and the successful outcome against Dillard's sends a message. We don't put up with people trying to profit off of our hard work," said Bug-A-Salt's President, Erika Schimik.

Bug-A-Salt's sales have been steadily increasing, even during the Covid 19 epidemic. Their products can be found at https://www.bugasalt.com/.

Bug-A-Salt (a subsidiary of Skell Inc.) this month prevailed in a patent and trademark infringement lawsuit against Dillard's Department Stores, according to the Bug-A-Salt, attorney, Liat Cohen, Esq.

Related link: https://liatlaw.com/

The Automotive Tissue Valet: A Car Tissue Holder

OVERLAND PARK, Kan. /ScoopCloud/ -- It's a clever idea and one that sprung from two near-miss accidents when Arlene Mathews, a registered nurse, and founder of Care Dynamics, Inc. attempted to grab a tissue while driving. She's now relaunched the product with a better look and design.

"Ahh...ahh...choo," Mathews says. "By the second 'ahh' you'll already have a tissue in hand when you hang the Automotive Tissue Valet from the passenger seat's headrest."

Mathews decided to change how the world stores tissues in motor vehicles after her second close call. The first time, she attempted to grab a tissue from a box on the back seat while she was driving and the second time; she tried to get a tissue out of a box on the passenger floor. Now, with the Automotive Tissue Valet, finding a tissue is safe and effortless.

Drivers can reach for a tissue without taking their eyes off the road. It has an adjustable strap and can easily be hung over the passenger seat headrest and to accommodate back seat passengers.

When Mathews first launched the product, she went through the usual new product development procedures of having a prototype made and identifying a manufacturer. After an order was placed and the product received, it was placed for sale on Amazon.

"And, while the item sold well and received great reviews, I decided it could be improved. The new and improved design has a tuck-lid opening for effortless tissue box insertion and material upgrade," she says.

After redesigning the product, a patent application was filed and a US Design Patent was granted.

The universal, neat uncluttered design fits the interior of any motor vehicle and protects the tissue box. In addition to making tissues accessible to drivers, unlike tissue holders that store tissues on the sun visor, or inside the console, the tissue valet makes tissues easily accessible to back seat passengers.

The Automotive Tissue Valet is made with very durable black polyester material and has a 10-year guarantee. It's available in two sizes - for flat and large size tissue boxes. It's also available for licensing and branding. Its design allows space for printing of a brand and/or logo.

Mathews believes that anyone with a nose in need of a tissue while in a motor vehicle, whether driver or passenger, will appreciate the Automotive Tissue Valet's convenience and usefulness.

It's currently available on:

Amazon: https://www.amazon.com/dp/B005KLCW5A

Walmart: https://www.walmart.com/ip/Automotive-Tissue-Valet-Front-Seat-The-BEST-solution-for-storing-facial-tissue-in-motor-vehicles/501435100.

MULTIMEDIA:

VIDEO (YouTube): https://youtu.be/5SA27tr9yOI

It's a clever idea and one that sprung from two near-miss accidents when Arlene Mathews, a registered nurse, and founder of Care Dynamics, Inc. attempted to grab a tissue while driving. She's now relaunched the product with a better look and design.

Organic Aromas Pioneers Again With Exciting New Market Leading Products: Receives New Trademark For Raindrop Design And Vows To Fight The Fakes

BOISE, Idaho /ScoopCloud/ -- Organic Aromas® (organicaromas.com), creator of the innovative nebulizing aromatherapy diffuser has once again introduced cutting edge products to the market. The Essential Oil Blending Lab Kit, The Attar Nebulizing Diffuser and the ultimate blending guide eBook are now available. The company has also received a new trademark for the Raindrop diffuser design.

The Essential Oil Blending Lab Kit

This is an ideal toolkit when you are practically looking to optimize your essential oil blending knowledge. Basically, you experiment with oils to come up with tailored blends that suit your lifestyle, taste and preference. This product contains handy glass tools and guiding stickers to ensure that you experiment effectively with various aromas to create, among others cleaning sprays, beauty hacks and many more. The kit is packaged in a compact container for easy use on the go.

The Attar Nebulizing Diffuser

The Attar Nebulizing Diffuser is a powerful 3-in-1 aromatherapy device. It is the largest diffuser in the market and works best in large spaces like conference rooms, theaters, warehouses, recreation centers and so on. This remarkable instrument is fitted with all the quality signature Organic Aromas diffuser features. It is uniquely made for large spaces and groups.

The Ultimate Blending eBook

This new e-guide is called "Transform Your Life With These Ten Therapeutic Essential Oil Blends." This blending resource is all you need to up your aromatherapy game. Enter the exciting world of fragrance notes and learn how to create winning therapeutic blends. This eBook guides you on how to activate the Blending Lab Kit. From safety information to the best blending practices, this product is paramount in adding vital blending skills to the user. Learn more: https://www.amazon.com/dp/B09473258G.

New Trademark For Raindrop Nebulizing Diffuser Design

Organic Aromas is now the United States sole trademark holder of the remarkable and iconic Raindrop diffuser design. This unique shape and appearance is part of the story and the success of Organic Aromas. The certification protects the design and seeks to end the production of fakes and imitations in the market. Our customers deserve the very best quality Raindrop diffuser, and the new trademark will guarantee this.

Organic Aromas Cares About Your Health, Submits Essential Oils for Testing with 3rd Party Lab!

Organic Aromas essential oils have been tested/analyzed for quality and safety by PhytoChemia; an independent laboratory licensed in Canada. 2021 lab results confirm that the oils have NO contaminants, diluents or adulterants. We deeply care about our clients' health and safety. These laboratory results are available on our website for perusal before purchasing.

About Organic Aromas

Organic Aromas is the leading aromatherapy brand - maker of the iconic Nebulizing Diffuser. The company also sells a host of premium quality essential oils and aromatherapy accessories. This innovative company is always adding exciting products to its portfolio to enhance and promote effective aromatherapy.

This video shows our masterpiece in action: https://youtu.be/LRHflGD9y-8

More information at: https://organicaromas.com/.

Organic Aromas, 1655 W. Fairview Ave. Ste 102, Boise, ID 83702

MEDIA CONTACT:
Mark Fackrell
Phone: 1 (208) 486 2857
email: info@organicaromas.com

*PHOTO link for media: https://www.Send2Press.com/300dpi/21-0719s2p-blending-lab-300dpi.jpg

*Caption: The Blending Lab Kit.

Organic Aromas®, creator of the innovative nebulizing aromatherapy diffuser has once again introduced cutting edge products to the market. The Essential Oil Blending Lab Kit, The Attar Nebulizing Diffuser and the ultimate blending guide eBook are now available. The company has also received a new trademark for the Raindrop diffuser design.

Related link: https://organicaromas.com/

Talon International Adjustec Division is Awarded Second US Patent: US 11,034,130 B2 for its Bandroll Technology

WOODLAND HILLS, Calif. /ScoopCloud/ -- The US Patent and Trademark Office (USPTO) recently awarded Talon's Adjustec a second patent in a series of patterns concerning their Adjustec stretch technology Bandroll product. The patent provides additional protection for the Adjustec Bandroll-the design behind Talon's Inventor of the Year Award for 2020, awarded by Aramark. Following this second patent are two more patterns pending for the Adjustec Bandroll that cover even a wider range of applications.

The Adjustec stretch technology has brought fashion to a new level of comfort and performance with their innovative stretch technology, using fusibles with any material. The Bandroll offers a stretch-fit solution for garments--particularly dress pant waistbands--providing a comfortable and durable fit that lasts a lifetime. Aramark the workwear Giant has adopted it as well in their quest to ensure they lead in providing performance in the workwear field.

Talon International has already been awarded three dress shirt design patents amongst 17 other granted patents for various product developments. Talon patents have been welcomed and adopted by several name brand clothing companies, including-but not limited to-Dockers, Uniqlo, Ralph Lauren, Round Tree and York, Murano, Van Heusen, Calvin Klein, Tommy Hilfiger, and Aramark workwear.

"We believe in innovation and technology, and we use patents to protect our intellectual property," says Larry Dyne, CEO of Talon International. "The modern production reality in the textile market is that anyone that tries to make these updated waistbands or collars without our approval, or a license from us, would, in fact, be infringing our patterns and pending patents."

Alongside creative design patterns, Talon's Adjustec division patents provide companies everywhere the opportunity to revolutionize the way they make fashion. With constant innovation in the fashion world, the Adjustec Bandroll provides the level of performance desired by buyers everywhere without sacrificing design and style.

"We believe that all modern pants...needs our technology to be competitive...Companies will also need our patented manufacturing systems and equipment to enjoy the incredible efficiencies and savings they provide," says Herman Roup, President and Inventor of Adjustec.

Since their revolutionary zipper invention in 1893, and over 128yrs of doing it right, Talon International remains committed to pushing boundaries with advanced, state-of-the-art design solutions, including trims, zippers, packaging, stretch technologies, and sustainable solutions. Talon is the solution for integrating invaluable, flexible, and sustainable products in the clothing we rely on every day. At Talon, Every. Detail. Matters.

For more information about the recently patented Adjustec Bandroll, see our website at https://taloninternational.com/product/bandroll/ or please contact Herman Roup by phone at 805-689-4656 or by email at HRoup@TalonTekfit.com.

*IMAGE link for media: https://www.Send2Press.com/300dpi/21-0708s2p-adjustec-300dpi.jpg

The US Patent and Trademark Office (USPTO) recently awarded Talon's Adjustec a second patent in a series of patterns concerning their Adjustec stretch technology Bandroll product. The patent provides additional protection for the Adjustec Bandroll-the design behind Talon's Inventor of the Year Award for 2020, awarded by Aramark. Following this second patent are two more patterns pending for the Adjustec Bandroll that cover even a wider range of applications.

Related link: https://taloninternational.com/

Fanplayr Issued U.S. Patent on Segmentation as a Service

PALO ALTO, Calif. /ScoopCloud/ -- Fanplayr, a leader in online behavioral personalization and artificial intelligence for the past decade, announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,958,743 which is related to the use of true first party observed data to offer behavior personalization focused on growing revenues for Fanplayr customers.

U.S. Patent No. 10,958,743 was issued on March 23, 2021 and covers the use of "Method and System for Segmentation as a Service" by Fanplayr.

"Segmentation as a Service" enables Fanplayr's powerful segmentation engine to be deployed for real-time segmentation with multiple apps, 3rd party systems, and combining first-party data with CRM and CDP historic data. The patent recognizes that Fanplayr is the only technology company offering segmentation as a broadly available service in the global ecommerce industry.

The technology disclosed in the patent modularizes the real-time evaluation of first-party data that reflects individual experiences and then defines an interface wherein the actions of remote, third-party services can be invoked. This enables such remote services to become increasingly fit for purpose without having to deal with the complexity and meaning of each individual visit. Such visits have context, such as purchase and visit history, site pattens and market trends, individual and collective behavioral indicators that remote services have limited awareness of.

Through the use of Segmentation As A Service, Fanplayr dramatically reduces the technical challenge of integrating state-of-art AI and IOT technologies and optimizes their relevance to each visit as it happens.

The patent includes various use cases that illustrate its claims, such as creating better visitor awareness in chatbots, survey widgets, credit calculation algorithms, cart margin evaluations and intelligent recommendations of products and articles.

The patent will remain in effect until 2038. Corresponding international patent filings in Europe, UK, China, HK, and Australia are pending grant.

At the heart of the Fanplayr method is true, first-party data which refers to information gathered in real-time, that is actionable as it happens, and originates from its primary source.

"In the current AdTech ecosystem, historical tracking data from cookies is not only less reliable but those third-party cookies are in the process of being phased out by pending privacy changes," says Derek Adelman, Co-founder and Vice President of APAC for Fanplayr. "Fanplayr's Seg-As-A-Service technology allows the customer to have confidence in services that have a more complete awareness of visitor experiences. Because they operate from data that is pure and actionable and see it as it happens, they not only deliver a consistently better result, but they can enjoy continuous improvement as these services become more visitor aware and more fit to their purpose."

Simon Yencken, Fanplayr CEO & Co-founder, says the technology required significant foresight and development. "Ten years ago, we saw that the future of the digital world would be understanding visitors in a responsive but non-intrusive way, as a digital replication of the interaction between a salesperson and a customer," says Yencken. "This patent recognizes the originality and uniqueness of our approach, thus protecting the intellectual property (IP) and establishing a strong defense from would-be competitors. We are extremely pleased with the patent issuance as a critical step in our product development, differentiation, and global expansion for Fanplayr."

With an enormous surge in e-commerce in the last year, Fanplayr's expansion has been driven by its ability to convert online users into buyers for companies of all sizes. Customers range from notable high-end fashion retailers and hotels to banking and major software brands. The company has expanded with operations in top global markets, including the U.S., United Kingdom, Mexico, Brazil, Japan, and the Middle East among others.

In addition to steadily increasing its global footprint, Fanplayr has announced several new services, or "products," in the past year, including Product Recommendations and SMS Messaging for brands. "Our goal is to offer a full range of products, to preserve the integrity of the data we capture and also to provide the most comprehensive system of artificial intelligence and behavior analysis available, thereby ensuring positive results for our customers," says Rajiv Sunkara, Co-founder and CTO of Fanplayr.

From its global headquarters in Palo Alto, California, Fanplayr has been leading fully integrated online personalization and AI for a decade. The company has achieved consistent growth of more than 60% annually over the last several years.

About Fanplayr

Fanplayr is a global leader in e-commerce behavioral data, using machine learning and AI to enable businesses to increase conversion rates and revenue, collect more leads, and retarget visitors with personalized recommendations during and after the shopping experience. Fanplayr is headquartered in Palo Alto, California with offices in New York, Buenos Aires, Brazil, Mexico, Milan, London, Manchester, Amsterdam, Stockholm, Hamburg, Melbourne and Tokyo.

Learn more at: https://www.fanplayr.com/

Media Contact:
Lacy Talton
(252) 467-5220
ltalton@percepture.com

*PHOTO link for media: https://www.Send2Press.com/300dpi/21-0414s2p-fanplayr-300dpi.jpg
*Photo Caption: Rajiv Sunkara, Simon Yencken and Derek Adelman.

Fanplayr, a leader in online behavioral personalization and artificial intelligence for the past decade, announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,958,743 which is related to the use of true first party observed data to offer behavior personalization focused on growing revenues for Fanplayr customers.

Related link: https://www.fanplayr.com/

Marijuana Home Gardens Announces its Outdoor Grow Hut Kit is Patent Pending – Legal in Arizona

TEMPE, Ariz. /ScoopCloud/ -- Tempe, Arizona-based, Marijuana Home Gardens announces it has filed for a patent on its turnkey Outdoor Marijuana Grow Hut Kit (USPTO application: US 63/163,586).

The passage of the Smart and Safe Act (Arizona Proposition 207) not only made the use of recreational marijuana legal in Arizona, but also, residents are now allowed to grow and harvest for personal use up to 12 marijuana plants per household.

A craft traditionally done indoors and in secret, the new law permits Arizona residents to come out of the shadows and grow high-value marijuana plants outdoors, which has substantial advantages to growing indoors.

With 5 years of experience in growing medicinal marijuana plants, company co-founder, Dante Schettino, has established a successful track record of not only growing outdoors, but all year long during extreme weather conditions from searing heat to freezing temperatures.

"Growing outdoors is tremendously cheaper, significantly safer, easier to maintain, and will result in larger yields," says co-founder Dante Schettino. "While there are plenty of indoor grow kits available for purchase in the marketplace, nobody has created an optimal system for growing outdoors."

For that reason, Schettino and his partners set out to create the Outdoor Grow Hut, a marijuana grow house that maximizes plant growth and minimizes all equipment and maintenance costs.

The Outdoor Grow Hut's patentable design presents a secure structure with limited visibility of the inside plants, but also allows a high degree of sunshine to reach the plants and provides natural air circulation.

The roof is convertible with an open design that permits maximum sunlight exposure during prime growing seasons and can be equipped with additional seasonal tops to protect plants from intense summer sun or trap heat for fall and winter plantings.

Arizona residents can purchase a complete Outdoor Grow Hut kit that includes premium organic super soil, seeds from a third party partner ( http://www.marijuanaseedconnect.com/ ), planter pots, and a watering system.

The company will deliver and install the structure, as well as plant the first seeds. The company also offers optional service contracts where skilled marijuana growers will come to its customers' homes on a weekly basis and cultivate the plants and treat the soil to ensure a constant crop.

"Similar to a pool cleaning service, we will come to your house and do all the gardening and you just sit back and enjoy the benefits," says Schettino.

Because marijuana legalization is a national trend, the company also provides complete Outdoor Grow Hut kits, less the premium organic super soil, for easy nation-wide shipping.

About Marijuana Home Gardens

Based in Tempe, Arizona, Marijuana Home Gardens makes the Outdoor Grow Hut Kit, provides gardening services, and other marijuana harvesting services for Arizona residents. For more information on Marijuana Home Gardens, visit http://www.outdoorgrowhut.com/ or contact us at info@outdoorgrowhut.com or call (480) 780-6763.

Instagram: outdoorgrowhut

Facebook: outdoorgrowhutkits

For more information on Marijuana Seed Connect, visit http://www.marijuanaseedconnect.com/

MEDIA ONLY CONTACT:
Dante Schettino
Marijuana Gardens AZ, LLC
info@marijuanahomegardens.com
(480) 780-6763

Tempe, Arizona-based, Marijuana Home Gardens announces it has filed for a patent on its turnkey Outdoor Marijuana Grow Hut Kit (USPTO application: US 63/163,586).

Related link: https://www.marijuanaseedconnect.com/

Zeteo Biomedical Receives US Patent for Innovative Sublingual Delivery Device for Vaccines and Pharmaceuticals

AUSTIN, Texas /ScoopCloud/ -- Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its "Oral Delivery Device and Methods" (US Patent 10238577). This latest patent expands the capabilities of Zeteo's ZEOx1™ Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route.

Sublingual delivery has emerged as a viable route of administration for vaccines and medications for pain, cardiovascular, allergy, seizure, sedation and emesis. The sublingual route avoids first pass metabolism and provides rapid systemic uptake into the body providing advantages over traditional oral medications.

Zeteo's latest innovations expand its ZEOx1 Hydra™ sublingual delivery device family that include configurations for mono-dose disposable and mono-dose reloadable dispensers for vaccines, drugs, biopharmaceuticals, biologics and botanical liquid formulations. "We see expanding demand for metered dose sublingual delivery devices that are easy to use, convenient to carry, deliver a precise dose and can be self-administered," said Timothy Sullivan, President of Zeteo Biomedical.

Zeteo's delivery device technology and product integration services enable pharmaceutical and biotech manufacturers to develop drug/device combination products that can extend or establish market exclusivity and competitive differentiation for new or existing drugs and biologics. The shift to developing value added, patient-centric products benefit the consumer through improved compliance and health outcomes while building brand value for the pharmaceutical or biotech manufacturer. Zeteo's delivery platforms and products are designed to meet the diverse demands of consumers and pharma manufacturers in globally competitive markets.

About Zeteo Biomedical LLC

Zeteo Biomedical™ is a biomedical device technology company based in Austin, Texas. Zeteo provides patient-centric delivery device technology and unit dose fill/finish packaging for pharmaceuticals, biopharmaceuticals, biologics and botanicals for intranasal, nose-to-brain, ophthalmic, sublingual, and animal care product applications.

For more information, please visit the Zeteo website at: https://www.zeteobiomed.com/

Media Contact
Cathy Diehl
Zeteo Biomedical LLC
+(1) 512-614-0144
zeteo@zeteobiomed.com

*LOGO link for media: https://www.send2press.com/300dpi/20-1117s2p-zeteo-biomedical-300dpi.jpg

Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its "Oral Delivery Device and Methods" (US Patent 10238577). This latest patent expands the capabilities of Zeteo's ZEO Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route.

Related link: https://www.zeteobiomed.com/

Caisson Biotech, LLC and Heparinex, LLC Announce Positive Examination Report of European Patent and the Discovery of a New Class of Sugar Polymers

AUSTIN, Texas /ScoopCloud/ -- Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new patent family will increase patent coverage across Europe, adding to the U.S. holdings.

The HEPtune platform, which utilizes heparosan, a naturally occurring polysaccharide, has been validated as a novel half-life extension and drug delivery alternative to commonly used polyethylene glycol (PEG). Unlike PEG, heparosan is naturally found in humans, is completely biodegradable, and will not trigger anaphylactic shock or anti-drug antibodies. The HEPtune platform has been applied to numerous drug classes including biologics, and small molecules via nanocarriers, including liposomes.

In addition to positive news received by the EPO, Heparinex is excited to announce that it has created a new class of sugar polymers, sulfated hepbiuronic acid (sHBA) that mimic some, but not all, of the desirable activities of heparin, a drug employed to treat many diseases including the fight against severe COVID-19 and influenza. These novel patent-pending drug candidates can quell the initiation of inflammation, but do not inhibit blood coagulation, thus can be used to protect organs such as the lungs, heart, and kidneys that are often damaged by the body's own defenses during disease without the risk of bleeding. The sHBA should be a useful addition to the arsenal of drugs currently dispensed to treat hyper-inflammation spawned by infectious, cardiovascular, and auto-immune diseases.

Heparosan conjugation was developed by Presidential Professor Dr. Paul DeAngelis at the University of Oklahoma Health Sciences Center (OUHSC) and includes a robust U.S. and international patent portfolio. "Our goal is to decipher and harness the natural 'sugar codes' in the body in more selective, customized fashion to target diseases and reduce side effects. We are excited by the possibilities for better medicines", said DeAngelis. He was named as one of the most influential researchers in the world according to a study led by an investigator at Stanford University and published in PLOS Biology.

About Caisson Biotech, LLC

Caisson Biotech, LLC is a collaboration driven biotechnology company specializing in the development of heparosan polymers to improve therapeutic drug delivery and performance. Caisson's HEPtune® technology was invented by Chief Scientist and University of Oklahoma Professor Dr. Paul DeAngelis, a world renowned glycobiology and enzyme specialist. Visit: https://caissonbiotech.com/.

Caisson Biotech is a subsidiary of Heparinex, LLC.

About Heparinex, LLC

Heparinex, LLC is a biopharmaceutical company focused on the novel recombinant synthesis of sugar-based compounds for markets including anticoagulation, inflammation, and cancer treatment. Dr. Paul DeAngelis originally discovered and patented Heparinex's core technology platforms of proprietary carbohydrate production. Visit: https://heparinex.com/.

Heparinex and Caisson are funded and managed by Emergent Technologies, Inc. an innovation solutions and technology commercialization leader headquartered in Austin, Texas. Visit: http://www.emergenttechnologies.com/

Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new patent family will increase patent coverage across Europe, adding to the U.S. holdings.

Related link: https://caissonbiotech.com/

Bug-A-Salt Files Patent Infringement Suit Against Dillard’s Inc.

LOS ANGELES, Calif. /ScoopCloud/ -- Skell, Inc., dba Bug-A-Salt, has filed suit against the department store chain Dillard's and its distributor, William E. Connor & Associates, for infringing on Skell's 2013 patent for a "bug killing gun," according to Bug-A-Salt's attorney, Liat Cohen.

The complaint was filed in United States District Court of Delaware, case 1:20-CV-01567-UNA.

In the suit, Loren Maggiore, the inventor of Bug-A-Salt, defines his invention as, "A 'gun' that uses table salt as particulate projectiles to stun or kill insects, particularly flies."

The patented Bug-A-Salt gun, which is safe around children and pets, has been on the market since 2013. More than three million Bug-A-Salt units have been sold; revenue from several versions of the product have resulted in sales in excess of $100 million.

In December 2019, Skell management became aware that Dillard's was offering for sale a near-identical Chinese-manufactured product it called "Salt War Gun." That same month, Skell sent a cease-and-desist letter to Dillard's, demanding they stop selling the counterfeit item. Dillard's responded they would do so, and later confirmed that the "Salt War Gun" had been removed from all of its stores. Subsequent investigation showed the patent-infringing product was still available at Dillard's in Florida and other Dillard's stores.

According to an article in the Jan. 26 issue of Barron's magazine, Dillard's was the second-most shorted small-cap stock on the Russell 2000 index, behind GameStop.

Little Rock, Arkansas-headquartered Dillard's has more than 300 locations in 29 US states.

"I first came up with this crazy idea more than 30 years ago, and never dreamt it would become the international success that it has," Maggiore says. "With Dillard's acknowledging our patent but not terminating its sales of its knock-off product, this is a case of the typical small entrepreneur fighting against the corporate giant refusing to do the right thing," he says.

To contact Liat Cohen, Esquire, regarding this suit, call (818) 579-9996 or email her at https://liatlaw.com/.

Skell, Inc., dba Bug-A-Salt, has filed suit against the department store chain Dillard's and its distributor, William E. Connor & Associates, for infringing on Skell's 2013 patent for a "bug killing gun," according to Bug-A-Salt's attorney, Liat Cohen.

Related link: https://liatlaw.com/

LuciGold Inc. is Helping Protect the Health and Safety of Our Community One Breath at A Time

EAST WAREHAM, Mass. /ScoopCloud/ -- LuciGold™ today announced the development of our newest product line, Hygeia (patent pending*), a custom designed line of furniture with built-in High Efficiency Particulate Air (HEPA) Filtration Systems.

Peter Luciani, the founder of LuciGold™, chose the name because he felt it to be most suitable for his new product line as Hygeia was the Ancient Greek Goddess of Good Health.

Hygeia is being introduced at a critical time during our healthcare crisis when we are trying to get children back in schools, employees out of their homes and back to the offices, patrons back to social activities, etc. The ongoing isolation that we as a community have been experiencing has had a profound negative impact on our emotional and mental wellbeing.

It is time there was a solution that would allow people to feel safer in environments where they will be gathering in close; proximity to one another and we feel that Hygeia furniture will assist in everyone getting back to the "old normal."

Hygeia products will be available to the public immediately. All the furniture is custom designed to meet the specifications of the environment where they will be installed.

FEATURES & BENEFITS of HYGEIA FURNITURE FILTRATION SYSTEMS

* HEPA filtration systems remove from the air that passes through it at least 99.95 (EU standard) or 99.97% (ASME, U.S. DOE standards) of particles whose diameter is equal to 0.03 μm; with the filtration efficiency increasing for particle diameter both less than and greater than 0.3μm.

* Fugitive Capture Design pulls exhaled breath through the vents on the top of the desk, restaurant table or bar into a plenum and through the HEPA filtration system reducing airborne transmission of viruses.

* 24/7 filtration with the HEPA filter to the entire room.

About LuciGold Inc.

LuciGold™ located in the heart of Buzzards Bay, Mass., has been family owned and operated since 2004. The owner, Peter J. Luciani, Jr., has been a problem-solver for over 40 years and the sole designer of the entire line of products and continues to develop solutions that address health and safety of the community. "When It Comes to Safety, We Are Committed to Top-of-the-Line Gold Standard."

Learn more at: https://www.LuciGoldHygeia.com

*NOTE: USPTO Patent application 29/760,562

Follow Us at:
- https://twitter.com/LucigoldH
- https://www.facebook.com/LuciGoldHygeia
- https://www.pinterest.com/218cr8vor25el9yzm0hb1t8czcrg0f/
- https://www.instagram.com/LuciGoldHygeia

MULTIMEDIA:

PHOTO link for media: https://www.Send2Press.com/300dpi/20-1214s2p-lucigold-hygiea-desk-300dpi.jpg

Caption: Hygiea Desks with vents that pull exhaled breath through a plenum and into the HEPA Filter

LuciGold today announced the development of our newest product line, Hygeia (patent pending*), a custom designed line of furniture with built-in High Efficiency Particulate Air (HEPA) Filtration Systems.

Related link: https://www.LuciGoldHygeia.com

FormFree Receives US Patent for Its Ground-Breaking Approach to Credit Decisioning

ATHENS, Ga. /ScoopCloud/ -- FormFree® has been granted Patent Number 10,769,723 for its proprietary 'Systems and Methods for Electronic Account Certification and Enhanced Credit Reporting' by the United States Patent and Trademark Office. The patent is expected to cover FormFree's technology, which analyzes direct-source financial data to determine a consumer's ability to repay any type of loan, offers a more accurate and comprehensive measurement of ability to pay (ATP) than traditional credit scoring.

The announcement underscores FormFree's focus on creating technologies that enable a more financially inclusive U.S. economy.

"This patent is another important milestone in strengthening our intellectual property position. Nearly 50 million Americans - disproportionately including the poor and minorities - lack a credit score and cannot obtain mortgages or other lending products," said FormFree Founder and CEO Brent Chandler. "FormFree understands that every consumer has a quantifiable ability to pay, not just those with a 720 or higher credit score. We are reimagining credit scoring with a new framework that provides a more complete understanding of what a person can actually afford than merely reviewing their repayment history."

Added Chandler, "Our multi-dimensional analysis of ability to pay allows lenders to instantaneously understand risk and make better credit decisions. It also democratizes lending by putting control of the process in the hands of borrowers, making it easier for consumers to seek out financial institutions that want their business."

The issued patent validates the innovation and novelty in FormFree's technology. FormFree was founded in 2008 by former Wall Street executive Brent Chandler. The company's pioneering work in bringing direct-source data analytics to the U.S. mortgage market has earned it six appearances on the HousingWire Tech100 list of the housing economy's most innovative companies, among other accolades. FormFree's AccountChek® and Passport(tm) solutions are used by thousands of lenders and millions of consumers each year.

About FormFree:

FormFree is a market-leading fintech company whose revolutionary products AccountChek and Passport are building a more inclusive credit decisioning landscape by encouraging lenders to view borrower ability to pay (ATP) more holistically. To date, thousands of U.S. lenders and brokers have ordered millions of FormFree's patented verification reports representing over a trillion dollars in loan verifications. FormFree delights borrowers and lenders with a paperless experience, reduces origination timelines by up to 20 days and offers automated analysis and standardized delivery to lenders and investors using a secure ReIssueKey™.

For more information, visit https://www.formfree.com/ or follow FormFree on LinkedIn https://www.linkedin.com/company/formfree/.

Twitter: @RealFormFree #patentnews #mortgageindustry #fintech

*LOGO link for Media: https://www.Send2Press.com/300dpi/17-0926s2p-formfree-300dpi.jpg

FormFree® has been granted Patent Number 10,769,723 for its proprietary 'Systems and Methods for Electronic Account Certification and Enhanced Credit Reporting' by the United States Patent and Trademark Office.

Related link: https://www.formfree.com/

Revealiency Announces Issuance of US Patent Covering AI-Powered Autonomous Emissions Testing, Analysis, and Reporting Technology

LEHI, Utah /ScoopCloud/ -- Revealiency (aka Emissions-Based Maintenance or EBM) is a Clean Technology company that focuses on optimizing compression ignition engine performance by sampling, and analyzing, engine exhaust using EBM Artificial Intelligence (AI) software to identify corrective maintenance actions that can be taken by engine owners.

Revealiency focuses on commercial and industrial engines that operate over long periods at high-duty cycles. Therefore, even small improvements identified by EBM's technology yields significant benefits.

Today, EBM proudly announces that it has secured US Patent No. US 2020/0109677 A1 - Engine emission status-based maintenance, which autonomously monitors exhaust-gases and provides actionable maintenance corrective actions that can be taken to improve engine performance. By doing so, this technology can also verify an engine is operating within specified parameters.

Benefits of the technology include: 1) reduced environmental impact, 2) lower operating costs, 3) enhanced engine reliability, and 4) improved engine life.

"I am pleased to see the development of this new EBM AI technology. It has been developed using decades of science-based research and hands-on experience with thousands of diesel engines," said Steve "Skinner" Forbush, Co-Founder and Lead Technical Engineer. "This patent leverages recent technological advancements in industrial IoT (telematics) devices with decades of emissions-based engine research."

EBM AI co-inventor and Revealiency Co-Founder and President, Jeramiah Forbush, added, "Many engine owners rely on OEM systems to monitor engine performance and assume that modern computer-controlled engines operate as they were designed. We have collected thousands of emissions tests and typically identify considerable opportunities to improve engine performance. This new AI technology allows for an increase in the frequency of emissions testing while completely automating the testing, analysis, and reporting functions."

For more information on how this patented technology might benefit your business, contact Jeramiah Forbush at jforbush@revealiency.com or (801) 901-8258.

About Revealiency

Revealiency is a clean technology company that focuses on improving commercial and industrial engine performance by identifying engine maintenance opportunities. This is done by sampling and analyzing engine exhaust using EBM AI technology. In recent projects, EBM AI has produced emissions and fuel savings of more than the 5%-7% targets. EBM has prided positive results with customers on six continents. Revealiency has identified corrective actions that can be taken to save over 2 Billion pounds of CO2 from the environment, which is equivalent to the annual CO2 production of over 900,000 automobiles.

Learn more at: https://revealiency.com/

Revealiency (aka Emissions-Based Maintenance or EBM) is a Clean Technology company that focuses on optimizing compression ignition engine performance by sampling, and analyzing, engine exhaust using EBM Artificial Intelligence (AI) software to identify corrective maintenance actions that can be taken by engine owners.

Related link: https://revealiency.com/

Patent Bots LLC Releases New Legal Rankings for Tracking Patent Quality

SOMERVILLE, Mass. /ScoopCloud/ -- Patent Bots today announced its Patent Law Firm Quality Scores, a new ranking of 802 U.S. patent law firms with at least 50 issued patents for the year ending March 31, 2020. Patent Bots downloaded 310,842 publicly available patents from the United States Patent and Trademark Office and then used the company's AI-powered, automated patent proofreading tool to count the number of errors in each issued patent. Issued patents identify the law firm responsible for the patent and also the company that owns the patent.

The Patent Law Firm Quality Scores provide public recognition for patent firms doing exceptionally high-quality work in avoiding legal errors in issued patents. The Quality Scores show the names of only the top fifty firms (e.g., those with the lowest number of errors per issued patent). Patent law firms outside of the top 50 can login to the Patent Bots website to see their own quality scores and where they stand with respect to other patent law firms.

"Automated patent proofreading helps decrease the number of errors in issued patents," says Jeff O'Neill, Patent Bots Founder and CEO. "Patent law firms are recognizing the importance of doing quality work and are subscribing to our proofreading tool to move up in our rankings."

Benefits of the Quality Scores rankings include:
* A novel, highly relevant, objective measure of the quality of work performed by patent law firms.
* Recognition for firms that score well, demonstrating their dedication to patent quality.
* A catalyst for underperforming firms to improve the quality of their work.

Patent Bots will update these rankings on a quarterly basis and highlight firms who are improving their Quality Scores. Moreover, Patent Bots plans on releasing more data-driven insights about other aspects of patent quality to improve the patent industry.

About Patent Bots:

Patent Bots' automated patent proofreading tool enables patent attorneys to use cutting edge machine learning to provide their clients with better patents. In addition to proofreading, Patent Bots has a suite of products that includes patent examiner statistics, an art unit predictor, patent family trees, patent timelines, and more.

Learn more at: https://www.patentbots.com/

*LOGO link for media: https://www.Send2Press.com/300dpi/20-0708s2p-patent-bots-llc-300dpi.jpg

Patent Bots today announced its Patent Law Firm Quality Scores, a new ranking of 802 U.S. patent law firms with at least 50 issued patents for the year ending March 31, 2020. Patent Bots downloaded 310,842 publicly available patents from the United States Patent and Trademark Office and then used the company's AI-powered, automated patent proofreading tool to count the number of errors in each issued patent.

Related link: https://www.patentbots.com/

Globest Trading Inc. and Internet Brand Development Resolve Pending Lawsuit with Canon

GLENDORA, Calif. /ScoopCloud/ -- Canon Inc., Globest Trading Inc., and Globest's parent company, Internet Brand Development (HK) Limited ("IBD"), have entered into a settlement agreement to amicably resolve the pending lawsuit between Canon and Globest in the Central District of California.

The lawsuit involved the compatible versions of Globest's toner cartridge models CF210X, CF211A, CF212A, CF213A, CB540A, CB541A, CB542A, CB543A, CE320A, CE321A, CE322A, CE323A, CRG-116, CRG-131H, CE410X, CE411A, CE412A, CE413A, CF380X, CF381A, CF382A, CF383A, CC530A, CC531A, CC532A, CC533A, CRG-118, PTCF210A, PTCF211A, PTCF212A, and PTCF213A, which are compatible with Canon toner cartridge models 116, 118, 131, and 131II and HP toner cartridge models 125A, 128A, 131A, 131X, 304A, 305A, 305X, 312A, and 312X, and seven patents that Canon alleged were infringed.

Globest disputed Canon's claim and filed a counterclaim for invalidity, which Canon denied.

To resolve the dispute, Globest agreed to a consent judgment and permanent injunction in which it agreed not to sell the compatible versions of the cartridges listed above that Canon alleged infringed its seven patents, or any similar version that infringes those patents. As part of the settlement, IBD and its affiliates also agreed not to sell those toner cartridges in the U.S. and various other countries.

Nothing in the settlement agreement prevents Globest or IBD from making, using, selling or offering for sale toner cartridges that do not infringe Canon's patents.

The seven patents at issue in the lawsuit are U.S. Patent Nos. 7,869,740 B2, 8,165,494 B2, 8,588,646 B2, 8,971,760 B2, 9,494,916 B2, 9,857,763 B2, and 10,162,304 B2.

Globest Trading is registered in California and sells ink and toner cartridges. IBD is registered in Hong Kong and its primary business is electronic products, office supplies, clothing, instruments and apparatuses and import/export.

Canon Inc., Globest Trading Inc., and Globest's parent company, Internet Brand Development (HK) Limited ("IBD"), have entered into a settlement agreement to amicably resolve the pending lawsuit between Canon and Globest in the Central District of California.

MICROSafeX Launches Kickstarter Campaign for World’s First ‘Unhackable’ Computer

LOS ANGELES, Calif. /ScoopCloud/ -- MICROSafeX announces a newly patented "unhackable" security technology / computer platform and it's working to raise money through a Kickstarter campaign set to launch on June 25, 2019 (US Patent No.: 10,061,923 B1).

Pritam Nath, founder of MICROSafeX, has been issued a hardware utility patent for an Internet-connected computer that cannot be hacked in any way whatsoever.

Nath has an engineering degree in electronic hardware from UCLA and more than 35 years of experience in systems architecture, large integrated software systems and some hardware in various computers, Internet, operating systems, BIOS, device drivers, embedded systems, and more. He has designed and built a fully functioning personal computer.

"This new hardware design is very different from all other computers on the market today," Nath says.

The company is working to raise funds for what it's calling, "the world's first unhackable computer."

"Computer hacking is a huge problem and this new technology solves problems ranging from viruses and malware to computer hijacking," Nath explains.

Hacking incidents and cyber security threats continue to make media headlines and only serve to illustrate the severity of the problem. MICROSafeX's new "unhackable computer" hopes to reduce and perhaps even eliminate these issues.

Criminals will no longer be able to steal valuable and confidential information from individuals, banks, corporations, hospitals, political organizations, government agencies and more.

While there are a few software security companies that offer software-only based solutions for virus and malware removal, they do not prevent cyber-attacks. MICROSafeX's hardware technology does.

The MICROSafeX-patented, hardware-based prevention system will not allow any virus or malware into the computer. The computer prototype is estimated to be available within 12 months and will retail for $1,250.

For more information, visit: https://microsafex.com/

VIDEO (Vimeo) - "Founders Statement" -- https://vimeo.com/337264307

Patent information: https://microsafex.com/patent/

MEDIA CONTACT:
Pritam Nath
of MICROSafeX
+1-310-873-8672
info@microsafex.com

*IMAGE link for media: https://www.Send2Press.com/300dpi/19-0619s2p-microsafex-300dpi.jpg

MICROSafeX announces a newly patented "unhackable" security technology / computer platform and it's working to raise money through a Kickstarter campaign set to launch on June 25, 2019 (US Patent No.: 10,061,923 B1).

Related link: https://microsafex.com/

FormFree Files Patent Application for Employer Data Extraction and Verification Tech

ATLANTA, Ga. /ScoopCloud/ -- FormFree today announced the filing of a patent application titled 'Method and System for Employer Verification,' which describes the company's proprietary method and system for verifying the employment and income history of loan applicants.

The methods and systems described in FormFree's confidential patent application include the following computer-implemented steps, among others:

* Electronically extracting one or more potential employer terms from a borrower's direct-deposit transactions
* Using natural-language processing and other artificial intelligence to identify potential employer names and comparing them against a database of known employer names to identify the borrower's employer(s)

Established in 2008, FormFree is a leading provider of electronic asset, income and employment verification. Its products help lenders of all sizes better assess the ability of borrowers to repay loans while removing the need for borrowers to supply paper documents to receive a mortgage or other type of loan.

Earlier this year, FormFree joined the Financial Data Exchange (FDX), a nonprofit group of the nation's most influential financial institutions and fintech companies that promotes information sharing and security standards for the financial sector.

"FormFree's approach to employment extraction and verification offers a distinct advantage over existing methods in the marketplace," said FormFree Chief Technology Officer Brian Francis. "We're proud to offer lenders a revolutionary way to assess borrower employment and income history with greater speed and accuracy."

About FormFree(R):

FormFree is a fintech company whose market-leading AccountChek(R) Asset Reports are used by lenders nationwide to verify borrower assets, employment and income in minutes. To date, more than 1,000 U.S. lenders have ordered over 1.25 million AccountChek Asset Reports, delighting their customers with a paperless experience and reducing origination timelines by up to 20 days. FormFree offers automated analysis and standardized delivery to lenders and their investors using a secure ReIssueKey(TM). A HousingWire TECH100(TM) company for four consecutive years, FormFree is based in Athens, Georgia.

For more information, visit https://www.formfree.com/ or follow FormFree on LinkedIn.

Twitter: @RealFormFree #patentfilings #technology

FormFree today announced the filing of a patent application titled 'Method and System for Employer Verification,' which describes the company's proprietary method and system for verifying the employment and income history of loan applicants.

Related link: https://www.formfree.com/

Carpe Diem Technologies Issued Critical NIL Patent for VR, Holographic, Microfluidic, and Integrated Printed Electronic Devices

FRANKLIN, Mass. /ScoopCloud/ -- Carpe Diem Technologies has been issued Patent US9804488 for the production of products incorporating NIL features. The system is entitled "System and method for fabricating miniature structures on a flexible substrate."

"The key claims in this patent allow manufacturers to fabricate and align nano-imprinted features with little or no apparent visual contrast," explains John S. Berg, Carpe Diem's founder and CEO.

Alignment and assembly is an increasingly important and difficult requirement for products whose performance is predicated on low-cost materials and extreme precision. These integrated optical and electronic products can now be made on low-cost substrates such as plastic film, flexible glass or even paper.

The patent's key claims facilitate roll-to-roll or flexible panel manufacturing of very precise complex devices - inexpensively.

Products enabled run the gamut from startups to mature industries.

Applications include (partial list):
* Virtual reality headgear and displays
* Document security and counterfeit prevention
* Active medical device patches
* Advanced high consumer impact labels and packaging
* Low-cost ultrafiltration filters for liquids and gasses
* High-capacity printed batteries
* High-efficiency energy generation from solar and thermal sources.

About Carpe Diem Technologies:
Carpe Diem brings high-precision volume manufacturing solutions to mature industries and startups alike. The company works in the world of nanometers to microns, frequently on low-cost flexible substrates such as paper, plastic, and metal foils or web.

Carpe Diem's modular machine system is for the development and production of nano-enabled printed electronics, microfluidics, meta materials and optical devices utilizing the most advanced processes. The manufacturing system has the flexibility to change with customers' needs and as technology evolves.

From NIL with NIL mastering capability to Spatial ALD. From printing to photolithography, with interferometric alignment and inspection. Carpe Diem's team, solutions, and approach power the new era of products and devices.

Learn more at: https://carpediemtech.com/.

*LOGO for Media: Send2Press.com/300dpi/18-0131s2p-carpediem-300dpi.jpg

Carpe Diem Technologies has been issued Patent US9804488 for the production of products incorporating NIL features. The system is entitled 'System and method for fabricating miniature structures on a flexible substrate.'The patent's key claims facilitate roll-to-roll or flexible panel manufacturing of very precise complex devices - inexpensively.

Related link: https://carpediemtech.com/

Ruling Affirms Patent Claim for Paragon BioTeck’s R-Phenylephrine Hydrochloride Formulation

PORTLAND, Ore., /ScoopCloud/ -- Paragon BioTeck, Inc. (Paragon), announces a monumental ruling handed down by the United States Patent and Trademark Office affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.

In late 2015, Altaire Pharmaceuticals, Inc., sought to invalidate Paragon's patent that claims a method of maintaining purity of the formulation. In only the fourth written decision by the Patent Trial and Appeals Board, the ruling affirms that the petition by Altaire Pharmaceuticals was without merit.

"While our belief in the strength of our patent was never in doubt, this is a tremendous win for Paragon BioTeck. This continues to reaffirm our belief and company mission behind the science and products we develop," said Patrick Witham, President & CEO.

Paragon is strongly dedicated to addressing unmet and underserved medical needs through product development that is based on cutting-edge science. Since its inception, Paragon has sought to partner with leading scientists and thinkers to drive innovations that advance patient care and improve the quality of lives around the world.

The patent ruling both reinforces the strong science underlying the formulation of Paragon's Phenylephrine Hydrochloride Ophthalmic Solution and substantiates the operational philosophy of the company.

Phenylephrine hydrochloride is widely used by eye care professionals to attain mydriasis (dilation of the pupil) for conducting an ocular examination. It is an indispensable tool for the early detection, diagnosis and treatment of serious eye diseases and is vital in managing ocular health.

About Phenylephrine Hydrochloride Ophthalmic Solution:

Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% and 10%, is an alpha-1 adrenergic receptor agonist used for dilation of the pupil due to its vasoconstrictor and mydriatic action. Phenylephrine possesses predominantly adrenergic effects. In the eye, phenylephrine acts locally as a potent vasoconstrictor and mydriatic by constricting ophthalmic blood vessels and the radial muscle of the iris.

Phenylephrine Hydrochloride Ophthalmic Solution Important Safety Information:

Phenylephrine Hydrochloride Ophthalmic Solution, USP 10%, is contraindicated in patients with hypertension or thyrotoxicosis, as well as in pediatric patients under the age of one due to the increased risk of systemic toxicity. Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5%, should not be used in these patients. Phenylephrine Hydrochloride Ophthalmic Solution, USP 10% and 2.5% is for topical ophthalmic use only, and not for injection.

Serious cardiovascular reactions, including ventricular arrhythmias and myocardial infarctions, some fatal, and significant elevations in blood pressure have been reported. Caution is advised in pediatric patients less than five years of age and in patients with elevated blood pressure, cardiovascular disease or hyperthyroidism. Blood pressure should be monitored in patients with cardiovascular or endocrine disease. Rebound miosis has been reported one day after instillation.

Ocular adverse reactions include eye pain and stinging on instillation, temporary blurred vision and photophobia. Cardiovascular adverse reactions include increase in blood pressure, syncope, myocardial infarction, tachycardia, arrhythmia and subarachnoid hemorrhage.

About Paragon BioTeck, Inc.:

Paragon BioTeck, Inc. ( https://paragonbioteck.com ), is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes. These products include the Comfortear(r) Lacrisolve(tm) 180 Absorbable Punctum Plug, Comfortear(r) Punctum Plug, the preservative-free ilast(r) range of products and their FDA-approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% and 10%.

Media Contact:
Allison Potter Howell
Senior Account Director
Pascale Communications, LLC
412-228-1678
allison@pascalecommunications.com

Paragon BioTeck, Inc. announces a monumental ruling handed down by the United States Patent and Trademark Office (USPTO) affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.

Bumpurr Mobile Dating App Files Patent Application for Wearable Offline GPS Indicator Embedded in Streetwear Label

NEW BRUNSWICK, N.J., Oct. 21, 2015 (SEND2PRESS NEWSWIRE) -- Bumpurr - a location based mobile dating app launching in 2016 - filed a Provisional Patent Application for its wearable offline GPS indicator technology in the USPTO on October 6, 2015. The Patent Pending technology will make Bumpurr the first to instantly connect members of an online mobile dating app to offline non-members.

According to founder Jet Wintzer, "Bumpurr will offer a streetwear clothing and accessories line embedded with our unique offline GPS transmitter logo. When a member of the Bumpurr community wears a product embedded with the logo - while logged into the app on their GPS enabled mobile phone - the logo transforms the online digital GPS beacon emitting from the user's handset into an offline GPS indicator."

When the Bumpurr user then has a real life encounter with a desirable passing stranger - who is not logged into the app - contact can be initiated by the stranger who receives the offline transmission, joins the app, and then uses its GPS perimeter search to instantly reveal the online profile of the Bumpurr member.

Every other location based mobile dating app on the market today offers only a confined set of potential suitors limited to people who are already members of the app. Bumpurr mobile dating technology enlarges that limited set of potential suitors to the unlimited set of the general public at large. No other mobile dating app instantly connects offline non-members to online member profiles.

Imagine you are riding the subway home from work, when a beautiful stranger looks up and smiles. Before you have a chance to overcome the anxiety of traditional courting obstacles, the train stops, and she's gone. But you noticed her ski cap branded with the Bumpurr logo/transmitter icon. So you visit the app and instantly join through a pre-existing social network. Your profile is created in seconds. You search the immediate perimeter for app members logged on near you, and there she is. You hit the bump button, and a notification is sent to her phone giving her access to your profile. If she bumps you back, your phones give an instant alert for the match, and you may then begin chatting.

Bumpurr also works just like other location based GPS dating apps, in that users can simply search generally for members logged on near them or miles away. After a match, the Bumpurr Eye Contact feature opens along with text chat. Eye Contact offers a sixty second window of silent live video where you can have a true eye-to-eye experience.

Bumpurr dating technology eliminates the utility of fake or misleading profiles by offering its users a genuine - what you see is what you get - experience before revealing intimate details and actually meeting other users in person.

For more information, follow Bumpurr on Twitter @bumpurr1; at https://www.facebook.com/bumpurr or by email - info@bumpurr.com.

ABOUT BUMPURR:

Based in New Brunswick, N.J., Bumpurr is a location-based GPS guided mobile dating app/streetwear line set to launch in 2016. Bumpurr(TM) and its logo are trademarks. Bumpurr GPS offline indicator technology is Patent Pending.

MEDIA CONTACT:
Jet Wintzer
info@bumpurr.com
(732) 374-9468

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/bumpurr-mobile-dating-app-files-patent-application-for-wearable-offline-gps-indicator-embedded-in-streetwear-label-2015-1021-04.shtml.

Vexti Signs License Agreement

BOSTON, Mass., Sept. 9, 2015 (SEND2PRESS NEWSWIRE) -- Vexti Corporation announced on July 21, 2015 it has entered into a licensing agreement with Northeastern University and Brown University based on research and intellectual property in the fields of antimicrobial surface coating and surface modification technologies.

The license includes rights to patents developed at both Brown University and Northeastern University, and was executed as a multi-party agreement.

"This cutting-edge technology developed by professor Thomas Webster, formerly at Brown University and currently the Art Zafiropoulo Chair in Engineering and chair of the Department of Chemical Engineering at Northeastern University, will have a significant impact in many consumer, medical, and industrial services and products," said Terry McGarty, co-founder of Vexti.

Vexti is a startup company focused on the commercialization of nanotechnology. The company's initial focus will be on the development of products for the consumer, medical, and industrial markets.

More information: http://www.vexticorp.com/.

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/vexti-signs-license-agreement-2015-0909-01.shtml.

NEWS SOURCE Vexti Corporation :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2015 Send2Press® Newswire, a service of Neotrope®.

U.S. Inventor Announces New Patent for Wind Turbine Industry

SAN FRANCISCO, Calif., March 4, 2014 (SEND2PRESS NEWSWIRE) -- Kamen George Kamenov, a U.S. inventor, today announced that he has patented a new way to support windmill blades and to triple the amount of energy extracted from the wind. Patent #8629570 has been assigned to these wind turbine blades with reinforcing, supporting and stabilizing components and enlarged swept area.

"This more efficient and effective way to harness wind power could seriously change the face of the alternative energy industry," Kamenov says.

And, with dwindling conventional energy sources for electricity production, wind power is on the rise. Natural energy forms, when properly managed, are inexhaustible.

It should also be noted that according to the U.S. Energy Information Administration, wind capacity will increase by 8.8 percent to about 66 gigawatts (GW) by the end of 2014 and will increase 14.6 percent to total more than 75 GW at the end of 2015.

So, this new invention for wind turbines is not only timely, but also well positioned for growth.

How do wind turbines work? Wind turbines convert the wind's kinetic energy into mechanical power through the use of a rotor with blades that spin a shaft.

The shaft is connected to a generator that converts the mechanical power into electricity. The swept area is the total area inside the imaginary circle, which the blades make when they turn under the wind pressure. The larger the swept area, the more wind energy is captured. However, if you double the length of the blades, the swept area increases four times.

"That is the secret of this invention - increasing the length of the blades with no additional cost and at the same time reinforcing them so that they don't break. Long blades are very expensive, unbalanced and can get damaged or break easily," Kamenov says.

The advantages of using wind energy are that it's renewable, nonpolluting and free. Disadvantages include diluted and unpredictable energy results, and high initial and maintenance cost.

This new invention is designed to meet many needs. They include the ability to reduce the cost of converting wind energy into electricity by providing a better construction and reinforcing and/or replacing the rotor and the blades with new and more efficient ones. It also hopes to use all wind potential, weak and strong and in more remote and high-location areas.

Available for licensing, some European, Chinese and Indian manufacturers and investors are already showing interest.

Patent specifics can be found here: http://www.google.com/patents/US8629570 or here: http://patft.uspto.gov/netahtml/PTO/srchnum.htm . Simply search for Patent #8629570, or contact the inventor at: kamengeorge@gmail.com; or kgkamenov@yahoo.com.

- Photo 300dpi: http://www.send2press.com/mediaboom/14-0304-wind-turbine_300dpi.jpg .
- Photo Caption: New Patent for Wind Turbine Industry.

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/U-S-Inventor-Announces-New-Patent-for-Wind-Turbine-Industry_2014-03-0304-002.shtml.

NEWS SOURCE Kamen George Kamenov :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2014 Send2Press® Newswire, a service of Neotrope®.

SecuGen Files Patent for New Optical Fingerprint Technology

SANTA CLARA, Calif., Sept. 25, 2013 (SEND2PRESS NEWSWIRE) -- SecuGen is pleased to announce that it has filed an application for a new patent at the U.S. Patent and Trademark Office. This new patent allows for the development of much more compact optical fingerprint readers and incorporates both scattering and absorption methods of fingerprint imaging in unique ways.

This patent is being implemented in a new line of SecuGen fingerprint readers. The first of these fingerprint readers is soon to be released and will be available worldwide through SecuGen's network of OEM, ISV, and Systems Integrator partners.

SecuGen is a world leading optical fingerprint products manufacturer. The SecuGen brand is known for products that are rugged, accurate, and affordable. This new patent is instrumental in giving SecuGen the ability to design a new product that is very compact and yet captures very high quality images.

Dan Riley, SecuGen's VP of Engineering stated, "Our engineering team is always trying to improve our products with the goal in mind of delivering the types of devices that our partners require. In this case that means a product that is FAP 20 certified, incredibly compact and priced to sell."

Won Lee, CEO of SecuGen added, "From the day we were founded in 1998 we have never stopped innovating. Now SecuGen has developed an important new patent that allows us to design and manufacture a new product that targets our 'sweet spot.' We have always been known as a company that can deliver rugged, accurate, and affordable fingerprint readers. Today we can add small and compact to that description."

About SecuGen:

SecuGen Corporation ( http://www.secugen.com/ ) is the world's leading provider of advanced, optical fingerprint recognition technology, products, tools and platforms for physical and information security. SecuGen designs and develops FBI-certified fingerprint readers and OEM components, developer kits and software, including NIST/MINEX-compliant algorithms. Known for high quality, ruggedness, and performance in a wide variety of applications and environmental conditions, SecuGen products are used by world-leading financial, medical, government, educational and corporate institutions and are sold through a partner network of over 200 original equipment manufacturers, independent software vendors and system integrators around the world.

SecuGen(R) is a registered trademark of SecuGen Corp. in the United States and other countries.

Sales Contact: SecuGen Sales Dept., +1-408-834-7712, sales@secugen.com.

SecuGen Corporation, 2065 Martin Avenue Suite 108, Santa Clara, Calif. 95050, USA.

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/SecuGen-Files-Patent-for-New-Optical-Fingerprint-Technology_2013-09-0925-001.shtml.

NEWS SOURCE SecuGen Corporation :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2013 Send2Press® Newswire, a service of Neotrope®.